Japan updates heart failure treatment guidelines for first time in a decade

Japan's cardiac societies released updated clinical guidance on diagnosing and treating heart failure, reflecting advances in drug therapies and device interventions since the last major revision. The refresh matters for hospitals, insurers, and drugmakers operating in Asia's second-largest economy, as it will likely shift treatment protocols and influence which therapies gain preferred status in clinical practice.

Originaltitel: JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure